Taiwan · Delayed Price · Currency is TWD HCmed Innovations Statistics
Total Valuation
TPE:6934 has a market cap or net worth of TWD 2.67 billion. The enterprise value is 2.35 billion.
| Market Cap | 2.67B |
| Enterprise Value | 2.35B |
Important Dates
The next estimated earnings date is Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPE:6934 has 35.97 million shares outstanding. The number of shares has increased by 10.68% in one year.
| Current Share Class | 35.97M |
| Shares Outstanding | 35.97M |
| Shares Change (YoY) | +10.68% |
| Shares Change (QoQ) | +2.96% |
| Owned by Insiders (%) | 25.76% |
| Owned by Institutions (%) | 15.88% |
| Float | 21.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.44 |
| PB Ratio | 5.04 |
| P/TBV Ratio | 5.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 21.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.09, with a Debt / Equity ratio of 0.19.
| Current Ratio | 9.09 |
| Quick Ratio | 8.33 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.64 |
| Interest Coverage | -58.56 |
Financial Efficiency
Return on equity (ROE) is -30.05% and return on invested capital (ROIC) is -16.55%.
| Return on Equity (ROE) | -30.05% |
| Return on Assets (ROA) | -15.65% |
| Return on Invested Capital (ROIC) | -16.55% |
| Return on Capital Employed (ROCE) | -21.10% |
| Weighted Average Cost of Capital (WACC) | 12.12% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.21 |
| Inventory Turnover | 4.33 |
Taxes
In the past 12 months, TPE:6934 has paid 10,000 in taxes.
| Income Tax | 10,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.04% in the last 52 weeks. The beta is 1.50, so TPE:6934's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | +15.04% |
| 50-Day Moving Average | 72.97 |
| 200-Day Moving Average | 84.67 |
| Relative Strength Index (RSI) | 52.40 |
| Average Volume (20 Days) | 27,766 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:6934 had revenue of TWD 109.19 million and -124.61 million in losses. Loss per share was -3.66.
| Revenue | 109.19M |
| Gross Profit | 11.62M |
| Operating Income | -129.94M |
| Pretax Income | -124.60M |
| Net Income | -124.61M |
| EBITDA | -114.45M |
| EBIT | -129.94M |
| Loss Per Share | -3.66 |
Balance Sheet
The company has 423.89 million in cash and 102.49 million in debt, with a net cash position of 321.40 million or 8.93 per share.
| Cash & Cash Equivalents | 423.89M |
| Total Debt | 102.49M |
| Net Cash | 321.40M |
| Net Cash Per Share | 8.93 |
| Equity (Book Value) | 529.57M |
| Book Value Per Share | 14.71 |
| Working Capital | 420.20M |
Cash Flow
In the last 12 months, operating cash flow was -100.12 million and capital expenditures -59.10 million, giving a free cash flow of -159.22 million.
| Operating Cash Flow | -100.12M |
| Capital Expenditures | -59.10M |
| Depreciation & Amortization | 15.49M |
| Net Borrowing | -15.50M |
| Free Cash Flow | -159.22M |
| FCF Per Share | -4.43 |
Margins
Gross margin is 10.64%, with operating and profit margins of -119.00% and -114.12%.
| Gross Margin | 10.64% |
| Operating Margin | -119.00% |
| Pretax Margin | -114.11% |
| Profit Margin | -114.12% |
| EBITDA Margin | -104.82% |
| EBIT Margin | -119.00% |
| FCF Margin | n/a |
Dividends & Yields
TPE:6934 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.68% |
| Shareholder Yield | -10.68% |
| Earnings Yield | -4.67% |
| FCF Yield | -5.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |